Acquiring third-party tested Selank and Selank Amidate requires rigorous analytical validation to ensure sequence fidelity, high purity, and freedom from residual contaminants. PX1 Research provides analytical-grade research peptides accompanied by lot-specific certificates of analysis (COA) from independent ISO 17025 accredited testing facilities, utilizing RP-HPLC and mass spectrometry to confirm compound identity and purity.
Acquiring third-party tested Selank and Selank Amidate requires rigorous analytical validation to ensure sequence fidelity, high purity, and freedom from residual contaminants. PX1 Research provides analytical-grade research peptides accompanied by lot-specific certificates of analysis (COA) from independent ISO 17025 accredited testing facilities, utilizing RP-HPLC and mass spectrometry to confirm compound identity and purity.
In contemporary peptide synthesis, sourcing third-party tested Selank is critical for maintaining experimental reproducibility across in vitro and preclinical research models. Selank (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide tuftsin. Due to the susceptibility of synthetic peptides to truncation sequences, counter-ion contamination, and oxidation during solid-phase peptide synthesis (SPPS), verification by an independent laboratory is mandatory.
A compliant third-party tested Selank batch must undergo dual-spectrum validation. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) measures chromatographic purity, ensuring that the target peptide peak constitutes at least 98% of total integrated peak area. Concurrently, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the precise monoisotopic mass of the compound, matching its theoretical molecular weight of 751.9 g/mol. Researchers evaluating suppliers should review lot-specific documentation within our comprehensive research hub to verify analytical methodology before initiating assays.
Beyond identity and purity, bioanalytical assessment must quantify bacterial endotoxin levels. Endotoxins (lipopolysaccharides) can artifactually activate immune receptors in cell culture or animal tissue models, skewing experimental outcomes. PX1 Research subjects every batch of our Selank research peptide to Kinetic Chromogenic LAL (Limulus Amebocyte Lysate) testing, guaranteeing endotoxin levels strictly below 0.05 EU/mg.
When evaluating synthetic regulatory peptides, investigators often choose between the native sequence and modified analogs. For assays requiring enhanced enzymatic resistance against carboxypeptidases, finding selank amidate third party tested materials is a top priority for analytical laboratories. The amidated variant—often referred to as Selank Amidate or N-Acetyl Selank Amidate—incorporates C-terminal amidation (and optionally N-terminal acetylation) to block enzymatic degradation pathways in biological matrices.
C-terminal amidation alters the net charge and polarity of the peptide chain, which manifests distinctly on analytical chromatograms. When analyzing selank amidate third party tested documentation, HPLC retention times shift relative to the native carboxyl-terminated Selank, and ESI-MS spectra confirm a mass shift corresponding to the functional group modification. For researchers investigating comparative peptide degradation kinetics, sourcing verified Selank Amidate ensures that observed half-life extensions are attributable to structural modification rather than sample impurity.
Both variants undergo identical quality assurance protocols at PX1 Research. Manufacturing takes place in domestic US facilities operating under strict Quality Management Systems (QMS). Every lot is cataloged with full raw data available for inspection, supporting the rigorous requirements of academic, clinical, and industrial investigative teams.
Preclinical literature demonstrates that Selank functions as a modulator of central neurotransmitter systems without direct agonism at classical benzodiazepine binding sites. In rodent models, researchers have observed that Selank modulates allosteric binding kinetics at the GABA-A receptor complex. In vitro binding assays indicate that the peptide alters the affinity of GABA-A receptors for endogenous gamma-aminobutyric acid, modulating inhibitory postsynaptic potentials.
Additionally, preclinical studies suggest that Selank influences serotonergic neurotransmission. Administration in animal models has been correlated with altered gene expression profiles of 5-HT1A receptors and transient shifts in 5-HT metabolite concentrations (such as 5-HIAA) within the hippocampus and prefrontal cortex. These mechanistic insights make Selank a primary subject of study in translational neurobiology.
Researchers exploring comparative neurochemical mechanisms can analyze our broader range of neuro-active research compounds available through the all peptides catalog. Utilizing analytical-grade materials ensures that recorded shifts in monoamine activity or receptor gene transcription stem directly from peptide-target interactions.
Because Selank is structurally derived from the immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg), preclinical investigations frequently focus on its immune-regulatory properties. In vitro cellular assays demonstrate that Selank influences the transcriptional regulation of various cytokines, including IL-6, TNF-alpha, and IFN-gamma, within primary splenocyte and leukocyte cultures.
Concurrently, animal studies indicate that Selank upregulates mRNA expression of Brain-Derived Neurotrophic Factor (BDNF) in hippocampal subfields. BDNF is a master regulator of synaptic plasticity, neuronal survival, and long-term potentiation (LTP). In murine models subjected to environmental stressors, Selank administration was observed to attenuate stress-induced declines in BDNF transcript levels.
To explore how structural modifications affect biological signaling pathways, researchers frequently compare Selank to other regulatory peptides. You can read more about structural peptide design in our research peptides documentation.
To contextualize Selank within preclinical neurobiology research, investigators often compare its mechanism and structural characteristics against other synthetic regulatory peptides and small molecules in the same research domain. Below is an overview comparing Selank with related compounds studied in cognitive and neuroprotective paradigms.
While Selank is a tuftsin derivative focusing on GABAergic and immune signaling, Semax is an ACTH(4-10) analog primarily evaluated for its effects on melanocortin receptors, BDNF release, and vascular endothelial growth factor (VEGF) expression. Conversely, BPC-157 represents a pentadecapeptide investigated for nitric oxide modulation and tissue repair pathways, whereas Noopept is a synthetic dipeptide derivative studied for AMPA receptor sensitization. Accessing pure, third-party verified forms of each compound allows research teams to establish controlled, head-to-head comparative assays.
To maintain valid experimental controls, research laboratories must establish strict acceptance criteria for incoming peptide shipments. Unverified compounds introduce variables such as TFA toxicity, peptide aggregation, or incorrect sequence synthesis that invalidate months of data collection.
PX1 Research adheres to an explicit quality standard across all product lots, ensuring complete transparency and compliance for laboratory use:
1. HPLC Purity Verification: Minimum 98% purity as measured by RP-HPLC integrated peak area. 2. Mass Spectrometry (MS): Confirmation of exact molecular weight via ESI-MS to eliminate sequence errors. 3. Endotoxin Quantitation: <0.05 EU/mg validated via Kinetic Chromogenic LAL assay. 4. Residual Solvent & Counter-Ion Analysis: Controlled TFA removal processes to prevent cellular toxicity in sensitive in vitro models. 5. Domestic Manufacturing: Synthesized in US-based, GMP-compliant facilities under strict quality oversight. 6. Lot Traceability & Logistics: Unique lot numbering paired with same-day shipping M–F from our CA and AZ distribution centers.
Lyophilized Selank and Selank Amidate are highly stable when stored under proper thermal conditions. Upon delivery, unopened vials should be maintained at -20°C for long-term preservation (up to 24 months) or 2°C to 8°C for short-term storage (up to 90 days). Exposure to light and moisture should be minimized by keeping vials inside sealed desiccant containers.
Reconstitution must be performed under a sterile laminar flow hood using appropriate laboratory solvents. For in vitro tissue culture or in vivo animal studies, sterile bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl) is recommended. The solvent should be directed down the glass wall of the vial rather than sprayed directly onto the lyophilized cake to prevent shear stress and peptide denaturation.
Once reconstituted, liquid aliquots should be stored at 2°C to 8°C and used within 30 days. Avoid repeated freeze-thaw cycles, as phase transitions induce peptide aggregation and cleavage. Laboratories requiring large quantities for longitudinal studies can set up custom supply protocols through our wholesale lab portal.
Supply chain delays can compromise thermal stability and disrupt sensitive laboratory testing schedules. PX1 Research mitigates these risks by maintaining fully stocked distribution hubs in California and Arizona, allowing rapid dispatch of analytical-grade materials across North America.
Orders placed before cut-off times are dispatched same-day Monday through Friday, utilizing temperature-controlled packaging when required. Every shipment includes a printed certificate of analysis corresponding directly to the lot number stamped on the vial label.
By enforcing strict manufacturing oversight, independent ISO 17025 third-party validation, and rapid domestic distribution, PX1 Research remains the preferred partner for academic, institutional, and private research entities demanding absolute chemical consistency.
Where can I find third-party tested selank with a verifiable COA?
PX1 Research provides third-party tested Selank accompanied by lot-specific Certificates of Analysis (COA). Every lot undergoes independent testing at an ISO 17025 accredited laboratory using RP-HPLC and ESI-MS to verify purity (≥98%) and correct molecular weight.
How do I verify a selank amidate third party tested report?
A valid COA for Selank Amidate must display an HPLC chromatogram showing a single dominant peak (≥98% area) and mass spectrometry data matching the molecular weight of the amidated sequence. PX1 Research publishes lot-specific analytical reports directly accessible for laboratory verification.
What is the difference between Selank and Selank Amidate in preclinical research?
Selank Amidate features a C-terminal amide modification (and often N-terminal acetylation) that increases resistance to carboxypeptidase cleavage in biological samples. This structural modification alters its enzymatic half-life in vitro without altering its fundamental target binding profile.
What purity level is required for Selank in laboratory research?
Preclinical and cell culture assays typically require a minimum purity of 98%. Lower purity peptides contain truncation sequences, uncoupled amino acids, or residual TFA that can cause off-target cellular toxicity and confound experimental results.
How is endotoxin testing performed on Selank batches?
Endotoxin quantitation is conducted using the Kinetic Chromogenic Limulus Amebocyte Lysate (LAL) assay. PX1 Research ensures that all research-grade Selank lots contain less than 0.05 EU/mg of bacterial endotoxins.
What is the recommended solvent for reconstituting lyophilized Selank?
For standard laboratory procedures, lyophilized Selank is typically reconstituted in sterile bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride solution under sterile hood conditions.
How should reconstituted Selank be stored in the lab?
Reconstituted Selank solutions should be stored at 2°C to 8°C and analyzed within 30 days. To avoid peptide degradation, researchers should aliquot the solution to prevent repeated freeze-thaw cycles.
Where is PX1 Research Selank manufactured and shipped from?
PX1 Research peptides are manufactured in US-based, GMP-compliant facilities and shipped directly from domestic fulfillment hubs in California and Arizona with same-day shipping available Monday through Friday.
Can Selank be used for human consumption or clinical administration?
No. All compounds supplied by PX1 Research, including Selank and Selank Amidate, are strictly intended for in vitro, biochemical, and preclinical laboratory research use only. They are not for human or veterinary medical use.
How does Selank compare to Semax in preclinical research models?
While both are regulatory synthetic peptides, Selank is a tuftsin-derived heptapeptide primarily studied for GABAergic, serotonergic, and immune modulation, whereas Semax is an ACTH(4-10) analog focused on melanocortin receptors and BDNF expression.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.